HIV tat and neurotoxicity
- PMID: 16697675
- DOI: 10.1016/j.micinf.2005.11.014
HIV tat and neurotoxicity
Abstract
HIV tat is the transactivator of HIV-1, supporting efficient viral replication by stabilizing the transcription of viral genes. Tat can be released from HIV-infected cells and alter several functions in uninfected cells. In the brain, tat induces neuronal dysfunction/toxicity, even though neurons cannot be directly infected with HIV, resulting in CNS pathology, such as the dementia and encephalitis associated with NeuroAIDS. This review discusses the most recent data addressing tat-induced neurotoxicity and integrates these new findings in the context of NeuroAIDS.
Similar articles
-
HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.Glia. 2005 Mar;49(4):501-10. doi: 10.1002/glia.20137. Glia. 2005. PMID: 15578658 Free PMC article.
-
Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.J Neurosci. 2003 Sep 10;23(23):8417-22. doi: 10.1523/JNEUROSCI.23-23-08417.2003. J Neurosci. 2003. PMID: 12968004 Free PMC article.
-
HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3438-43. doi: 10.1073/pnas.0611699104. Epub 2007 Feb 21. Proc Natl Acad Sci U S A. 2007. PMID: 17360663 Free PMC article.
-
Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.Curr HIV Res. 2007 May;5(3):301-13. doi: 10.2174/157016207780636515. Curr HIV Res. 2007. PMID: 17504172 Review.
-
HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.Brain Res Brain Res Rev. 2005 Dec 1;50(1):14-26. doi: 10.1016/j.brainresrev.2005.04.002. Brain Res Brain Res Rev. 2005. PMID: 15890409 Review.
Cited by
-
Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.J Leukoc Biol. 2012 Mar;91(3):401-15. doi: 10.1189/jlb.0811394. Epub 2012 Jan 6. J Leukoc Biol. 2012. PMID: 22227964 Free PMC article. Review.
-
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration.Exp Neurol. 2021 Jul;341:113699. doi: 10.1016/j.expneurol.2021.113699. Epub 2021 Mar 15. Exp Neurol. 2021. PMID: 33736974 Free PMC article.
-
Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure.PLoS One. 2012;7(5):e37540. doi: 10.1371/journal.pone.0037540. Epub 2012 May 22. PLoS One. 2012. PMID: 22629415 Free PMC article.
-
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.PLoS One. 2022 Sep 28;17(9):e0275182. doi: 10.1371/journal.pone.0275182. eCollection 2022. PLoS One. 2022. PMID: 36170295 Free PMC article.
-
Mechanism for HIV-1 Tat insertion into the endosome membrane.J Biol Chem. 2009 Aug 21;284(34):22736-46. doi: 10.1074/jbc.M109.023705. Epub 2009 Jun 23. J Biol Chem. 2009. PMID: 19549783 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical